Business Wire

X2nSat Selects LeoSat’s Laser-Enabled Data Network to Support Healthcare Communications

Share

LeoSat Enterprises, which is launching a constellation of 108 low-earth-orbit communications satellites that will provide the fastest, most secure and widest coverage data network in the world, today announced that X2nSat, the highly reliable satellite solutions provider, has selected LeoSat to support new infrastructure solutions for the ever-expanding needs of the healthcare industry.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190506005302/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

New Satellite Constellation providing the first business backbone in space for Enterprise Data. (Photo: Business Wire)

X2nSat currently offers SatBlue, a proprietary line of voice and data communications solutions tailored for the healthcare industry (including data and internet redundancy, emergency response trailers and telemedicine capabilities), which allows hospitals and medical office buildings to customize communications solutions based on their existing infrastructure, and to expand when the need for additional capabilities arises.

Whether it is through telemedicine, video conferencing or transferring medical records via broadband, hospitals and medical facilities have unique needs when it comes to communications. Network reliability and scalability are key for both service continuity and disaster recovery plans. With healthcare, a back-up communications system not only keeps the business running, it can help save lives.

With data volumes exploding, the increasing demand to move large quantities of data quickly and securely around the world is fast outpacing the infrastructure needed to carry it. LeoSat has developed a unique system architecture – a space-based MPLS network - providing Gigabits of secure connectivity with lower latencies than fiber, opening-up new possibilities for Healthcare providers looking for scalable, flexible solutions for their expanding networks.

Garrett Hill, CEO of X2nSat, said: “Technology is crucial to Healthcare. With cloud computing and Big Data becoming more and more prominent, healthcare providers are seeking a reliable, disaster-resistant backbone for effective healthcare IT management. Satellite is the missing puzzle piece for the delivery of reliable communication and data connectivity. LeoSat’s unique high throughput, low latency and highly secure data communications network will enable us to offer new data and voice connectivity solutions and work closely with healthcare providers to create effective disaster preparedness plans”.

As part of the agreement, Hill receives a designated seat on LeoSat’s Customer Technical Advisory Committee, an institution created to structure collaboration and exchange information surrounding the design, configuration, production, and launch of the LeoSat satellite constellation. Says Hill, “X2nSat’s Las Cruces, New Mexico Satellite Gateway has been designed and optimized for high-throughput satellites, and X2nSat is looking forward to collaborating with LeoSat on how best to deliver the latest generation of solutions to our enterprise customers”.

Michael Abad-Santos, SVP Americas, LeoSat said: “Satellite is often seen as a last resort for enterprise data communications. But with capabilities beyond existing satellite and fiber, including transmission speeds of 5.2 gigabits per second and latency of 20 milliseconds, LeoSat’s infrastructure is what data communications has been waiting for – a game-changing service which realizes the synergies of both worlds to re-define connectivity in terms of capacity, latency, security, efficiency and coverage. Using our unique backbone in space we can provide fast and ultra-secure point-to-point data connections to and from anywhere on earth without the need for any terrestrial landings”.

LeoSat is backed by leading satellite operators SKY Perfect JSAT and Hispasat, and the system is being developed in conjunction with Thales Alenia Space, a company with unmatched expertise in designing and manufacturing low earth orbit constellations. The high-throughput satellites (HTS) in the constellation will form a mesh network interconnected through laser links, creating an optical backbone in space which is about 1.5 times faster than terrestrial fiber backbones, thus creating a paradigm shift in the use of satellites for data connectivity – rather than a gap filler or last resort where no terrestrial alternative is available. LeoSat has already secured over 2 Billion USD in pre-launch customer agreements and was recently granted a license by the FCC to operate its network in the U.S. ENDS

NOTE TO EDITORS

To find out more about LeoSat, come along to one of the panels at Sat2019. To arrange an interview, please contact Melanie Dickie. Email: Melanie@leosat.com or call +31 6 14 22 97 62.

  • Monday 6 May, 1.30pm: An Introduction to HTS and Other Acronyms (Unveiled Theater)
  • Wednesday 8 May, 3pm: Integrating LEO Constellations Into Teleport Services (Room 147)
  • Thursday 9 May, 10:45am: Executive Round Table – LEO/MEO Systems (Room 146)

About LeoSat Enterprises

LeoSat Enterprises was established to leverage the latest developments in satellite communications technologies to develop and launch a new low-earth-orbit satellite constellation which will provide the first commercially available, business grade, extremely high-speed and secure data service worldwide. With up to 108 low-earth-orbit communications satellites in the constellation LeoSat is the first company to have all the High Throughput Satellites (HTS) in the constellation interconnected through laser links, creating an optical backbone in space which is about 1.5 times faster than terrestrial fiber backbones and without the need for any terrestrial touchpoints. This unique set of features enables LeoSat to provide instant infrastructure from anywhere to everywhere which is fast, secure and reliable.

Based in Washington DC, LeoSat is currently working with Thales Alenia Space for the low-earth-orbit constellation of Ka-band communications satellites. Once operational, the constellation will provide high-speed, low-latency and highly secure communications and bandwidth for business operations in the telecom backhaul, Energy, Maritime, Government and international business markets. Launch of the constellation is expected in 2020. www.leosat.com

About X2nSat

Founded in 1996, X2nSat provides highly reliable wireless network and communications solutions, with a commitment to making the world, business and life better with reliable communication anytime, anywhere. Working “above the cloud,” X2nSat offers the robust services of a large telecommunications company with the personalized customer care of a specialty organization, and is a leading provider of satellite technology to enterprise organizations in healthcare, utilities, and other industries. For more information, visit www.X2nSat.com.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Melanie Dickie
VP Marketing & Communications, LeoSat Enterprises
Tel: +31 6 14 22 97 62
Email: melanie@leosat.com

Media Contact for X2nSat:
Jena Blazer, Director of Sales and Marketing
+1.707.664.5712
jena.blazer@x2nsat.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

CORRECTING and REPLACING PHOTO Decode the Future of AI and Customer Experience at Elevate'25 Digital Innovation Summit18.9.2025 21:23:00 EEST | Press release

Please replace the photo with the accompanying corrected photo. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250918928987/en/ Gain insight and advice from firms at the frontier of AI-powered, mobile-first customer experiences. The release reads: DECODE THE FUTURE OF AI AND CUSTOMER EXPERIENCE AT ELEVATE'25 DIGITAL INNOVATION SUMMIT With keynotes from Google Cloud and an independent research firm, Elevate’25 will provide actionable strategies to harness the power of AI and create exceptional experiences for today's mobile-first consumer As unprecedented advancements in AI reshape consumer behavior, digital innovation summit Elevate'25 opened for general registration today. Sponsored by Airship, the exclusive, one-day event is designed to equip business leaders with proven strategies to harness artificial intelligence and mobile-first technology for a decisive competitive advantage. Taking place on October 15, 2025, at the i

Sai Life Sciences Opens Dedicated Facility for Veterinary APIs in Bidar, India18.9.2025 19:22:00 EEST | Press release

Sai Life Sciences (BSE: 544306 | NSE: SAILIFE), an innovator-focused Contract Research, Development, and Manufacturing Organization (CRDMO), today announced the opening of Unit VI, a dedicated facility for Veterinary Active Pharmaceutical Ingredient (API) production, in Bidar, India. Located alongside Unit IV, the company’s flagship API manufacturing site, Unit VI has been established exclusively for veterinary APIs. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250918612071/en/ Sai Life Sciences’ Veterinary APIs Unit in Bidar, India. The new facility is designed to meet the highest standards of safety, sustainability, and regulatory compliance, ensuring the production of high-quality APIs for veterinary applications. With this expansion, Sai Life Sciences aims to provide efficient and scalable manufacturing solutions to leading global animal health companies. Making the announcement, Krishna Kanumuri, CEO & Managing Direct

Celltrion Announces Commercial Availability of Omlyclo™ Across Europe at EADV 202518.9.2025 18:45:00 EEST | Press release

Celltrion, Inc. today showcased its longstanding commitment to expanding its biosimilar portfolio in the field of immuno-dermatology by attending the 2025 European Academy of Dermatology and Venereology (EADV) Congress, held 17-20 September in Paris, France. Following the European Commission (EC) approval of Omlyclo™, the first and only omalizumab biosimilar in Europe in May 2024, Omlyclo™ will be commercially available starting in Norway, with subsequent rollouts in European countries. As part of Celltrion’s mission to advance knowledge and understanding in dermatology, especially in chronic spontaneous urticaria (CSU), the company hosted satellite symposium presenting the results of the global Phase III clinical trial of Omlyclo™. The global Phase III clinical trial involved 619 patients with CSU, following them up to week 40. Patients were randomized to receive 300 mg or 150 mg of Omlyclo™, or reference product, every 4 weeks. Starting from week 12, patients who received Omlyclo™ we

Setting the Standard: AMRA Medical Recognized as one of TIME Magazine’s ‘World’s Top HealthTech Companies’18.9.2025 17:40:00 EEST | Press release

AMRA Medical is proud to share its inclusion in the World’s Top HealthTech Companies list, published today by TIME in collaboration with Statista. This recognition positions AMRA among an elite group of global innovators that are leading healthcare transformation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250918372780/en/ AMRA Medical Recognized as one of TIME Magazine’s ‘World’s Top HealthTech Companies’ The selection, which comes just one week after celebrating AMRA’s 15 years of progress and innovation within the body composition space, highlights AMRA’s long-standing commitment to becoming a global leader in health informatics. By delivering detailed, reproducible insights within fat distribution and muscle composition, AMRA’s MRI-based technology is helping clinicians, researchers, and healthcare organizations unlock new levels of understanding across the metabolic and musculoskeletal sectors. “Being recognized by

illumynt, a CNE Direct Company, Is Pleased to Announce the Promotion of Jörg Herbarth to Chief Executive Officer (CEO)18.9.2025 17:30:00 EEST | Press release

illumynt, a CNE Direct company, is pleased to announce the promotion of Jörg Herbarth to Chief Executive Officer (CEO). Jörg has been a key member of illumynt’s executive leadership team since joining in June 2022, most recently serving as Chief Operating Officer. In his new role as CEO, Jörg will spearhead illumynt’s mission to become the number one provider of AI- and data-centric IT Asset Disposition (ITAD) solutions worldwide. Paul Knight, illumynt’s current CEO, will transition to the role of Founder & Chairman. In this capacity, Paul will continue to support the executive team with strategic guidance, while Jörg assumes full leadership of day-to-day operations and global expansion initiatives. Mr. Knight had come out of retirement a year ago to undertake some new initiatives and advance the company's strategic direction. With some necessary changes having taken place- he is thrilled to facilitate this transition to a reduced role again. Under Jörg’s leadership, illumynt will cont

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye